ALPMY
Price
$9.82
Change
-$0.03 (-0.30%)
Updated
Dec 17 closing price
43 days until earnings call
BAYRY
Price
$5.03
Change
-$0.06 (-1.18%)
Updated
Dec 17 closing price
77 days until earnings call
Ad is loading...

ALPMY vs BAYRY

Header iconALPMY vs BAYRY Comparison
Open Charts ALPMY vs BAYRYBanner chart's image
Astellas Pharma
Price$9.82
Change-$0.03 (-0.30%)
Volume$440.19K
CapitalizationN/A
Bayer A.G
Price$5.03
Change-$0.06 (-1.18%)
Volume$2.64M
CapitalizationN/A
ALPMY vs BAYRY Comparison Chart
Loading...
ALPMY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BAYRY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ALPMY vs. BAYRY commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALPMY is a Hold and BAYRY is a Hold.

COMPARISON
Comparison
Dec 19, 2024
Stock price -- (ALPMY: $9.82 vs. BAYRY: $5.03)
Brand notoriety: ALPMY and BAYRY are both not notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: ALPMY: 226% vs. BAYRY: 164%
Market capitalization -- ALPMY: $26.55B vs. BAYRY: $57.55B
ALPMY [@Pharmaceuticals: Major] is valued at $26.55B. BAYRY’s [@Pharmaceuticals: Major] market capitalization is $57.55B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $739.66B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $86.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALPMY’s FA Score shows that 1 FA rating(s) are green whileBAYRY’s FA Score has 0 green FA rating(s).

  • ALPMY’s FA Score: 1 green, 4 red.
  • BAYRY’s FA Score: 0 green, 5 red.
According to our system of comparison, both ALPMY and BAYRY are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALPMY’s TA Score shows that 4 TA indicator(s) are bullish while BAYRY’s TA Score has 6 bullish TA indicator(s).

  • ALPMY’s TA Score: 4 bullish, 4 bearish.
  • BAYRY’s TA Score: 6 bullish, 2 bearish.
According to our system of comparison, BAYRY is a better buy in the short-term than ALPMY.

Price Growth

ALPMY (@Pharmaceuticals: Major) experienced а -4.94% price change this week, while BAYRY (@Pharmaceuticals: Major) price change was -5.27% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was -2.43%. For the same industry, the average monthly price growth was -3.05%, and the average quarterly price growth was -6.42%.

Reported Earning Dates

ALPMY is expected to report earnings on Jan 30, 2025.

BAYRY is expected to report earnings on Mar 05, 2025.

Industries' Descriptions

@Pharmaceuticals: Major (-2.43% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BAYRY($57.5B) has a higher market cap than ALPMY($26.6B). ALPMY has higher P/E ratio than BAYRY: ALPMY (37.59) vs BAYRY (17.04). ALPMY YTD gains are higher at: -15.772 vs. BAYRY (-45.066). ALPMY has higher annual earnings (EBITDA): 247B vs. BAYRY (12.1B). ALPMY has more cash in the bank: 397B vs. BAYRY (7.98B). ALPMY has higher revenues than BAYRY: ALPMY (1.52T) vs BAYRY (50.5B).
ALPMYBAYRYALPMY / BAYRY
Capitalization26.6B57.5B46%
EBITDA247B12.1B2,041%
Gain YTD-15.772-45.06635%
P/E Ratio37.5917.04221%
Revenue1.52T50.5B3,008%
Total Cash397B7.98B4,978%
Total Debt30BN/A-
FUNDAMENTALS RATINGS
ALPMY vs BAYRY: Fundamental Ratings
ALPMY
BAYRY
OUTLOOK RATING
1..100
604
VALUATION
overvalued / fair valued / undervalued
1..100
6
Undervalued
34
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
7979
PRICE GROWTH RATING
1..100
7686
P/E GROWTH RATING
1..100
10091
SEASONALITY SCORE
1..100
5095

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ALPMY's Valuation (6) in the null industry is in the same range as BAYRY (34). This means that ALPMY’s stock grew similarly to BAYRY’s over the last 12 months.

ALPMY's Profit vs Risk Rating (100) in the null industry is in the same range as BAYRY (100). This means that ALPMY’s stock grew similarly to BAYRY’s over the last 12 months.

ALPMY's SMR Rating (79) in the null industry is in the same range as BAYRY (79). This means that ALPMY’s stock grew similarly to BAYRY’s over the last 12 months.

ALPMY's Price Growth Rating (76) in the null industry is in the same range as BAYRY (86). This means that ALPMY’s stock grew similarly to BAYRY’s over the last 12 months.

BAYRY's P/E Growth Rating (91) in the null industry is in the same range as ALPMY (100). This means that BAYRY’s stock grew similarly to ALPMY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ALPMYBAYRY
RSI
ODDS (%)
Bullish Trend 2 days ago
61%
Bullish Trend 2 days ago
55%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
59%
Bullish Trend 2 days ago
46%
Momentum
ODDS (%)
Bearish Trend 2 days ago
64%
Bullish Trend 2 days ago
52%
MACD
ODDS (%)
Bearish Trend 2 days ago
75%
Bullish Trend 2 days ago
62%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
65%
Bearish Trend 2 days ago
71%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
67%
Bearish Trend 2 days ago
66%
Advances
ODDS (%)
Bullish Trend 16 days ago
64%
Bullish Trend 10 days ago
58%
Declines
ODDS (%)
Bearish Trend 2 days ago
67%
Bearish Trend 2 days ago
71%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
63%
Bullish Trend 6 days ago
58%
Aroon
ODDS (%)
Bearish Trend 2 days ago
68%
Bearish Trend 2 days ago
68%
View a ticker or compare two or three
Ad is loading...
ALPMY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BAYRY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME31.261.82
+6.18%
GameStop Corp
TSLA479.8616.84
+3.64%
Tesla
AAPL253.482.44
+0.97%
Apple
BTC.X106140.600000110.890625
+0.10%
Bitcoin cryptocurrency
SPY604.29-2.50
-0.41%
SPDR® S&P 500® ETF Trust

ALPMY and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALPMY has been loosely correlated with ALPMF. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if ALPMY jumps, then ALPMF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALPMY
1D Price
Change %
ALPMY100%
-0.30%
ALPMF - ALPMY
37%
Loosely correlated
N/A
OPHLY - ALPMY
32%
Poorly correlated
-1.41%
OTSKY - ALPMY
21%
Poorly correlated
-1.45%
BAYRY - ALPMY
13%
Poorly correlated
-1.18%
ABBV - ALPMY
12%
Poorly correlated
+2.18%
More

BAYRY and

Correlation & Price change

A.I.dvisor indicates that over the last year, BAYRY has been closely correlated with BAYZF. These tickers have moved in lockstep 88% of the time. This A.I.-generated data suggests there is a high statistical probability that if BAYRY jumps, then BAYZF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BAYRY
1D Price
Change %
BAYRY100%
-1.18%
BAYZF - BAYRY
88%
Closely correlated
-0.51%
OPHLY - BAYRY
23%
Poorly correlated
-1.41%
AZNCF - BAYRY
20%
Poorly correlated
+1.29%
CSPCY - BAYRY
20%
Poorly correlated
+0.56%
ALPMY - BAYRY
13%
Poorly correlated
-0.30%
More